These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8789699

  • 21. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis.
    Kuzmin AI, Tskitishvili OV, Serebryakova LI, Kapelko VI, Majorova IV, Medvedev OS.
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):564-71. PubMed ID: 7596124
    [Abstract] [Full Text] [Related]

  • 22. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals.
    Hoey BM, Butler J, Halliwell B.
    Free Radic Res Commun; 1988 Apr; 4(4):259-63. PubMed ID: 2852627
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Allopurinol: a comparative study of the bioavailability and effect on plasma uric acid of two products in tablet form.
    Nissen P, Pedersen L.
    Biopharm Drug Dispos; 1985 Apr; 6(4):441-6. PubMed ID: 4084669
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
    Spector T.
    Biochem Pharmacol; 1988 Jan 15; 37(2):349-52. PubMed ID: 2829916
    [Abstract] [Full Text] [Related]

  • 37. Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion.
    Masaoka N, Nakajima Y, Hayakawa Y, Ohgame S, Hamano S, Nagaishi M, Yamamoto T.
    J Matern Fetal Neonatal Med; 2005 Jul 15; 18(1):1-7. PubMed ID: 16105785
    [Abstract] [Full Text] [Related]

  • 38. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M, Fujita K, Toyoda Y, Takada T, Hasegawa H, Ichida K.
    Drug Metab Pharmacokinet; 2018 Feb 15; 33(1):77-81. PubMed ID: 29342419
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.